Evidence map›Paper›PMID 33336932›Full record

ArticleCancer medicine2021

Risk factors and their diagnostic values for ocular metastases in invasive ductal carcinoma.

Rong-Bin Liang, Kang Yu, Jie-Li Wu, Jia-Xiang Liu, Qi Lin, Biao Li, Yu-Qing Zhang, Qian-Min Ge, Qiu-Yu Li, Hui-Ye Shu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Apolipoproteins: New players in cancers.Frontiers in pharmacology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Rong-Bin LiangDepartment of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Kang YuDepartment of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Jie-Li WuDepartment of Ophthalmology, Xiang'an Hospital of Xiamen University, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute of Xiamen University, Xiamen University School of Medicine, Xiamen, Fujian Province, China.
Jia-Xiang LiuDepartment of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.ORCID 0000-0002-9717-7472
Qi LinDepartment of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.ORCID 0000-0002-9742-1674
Biao LiDepartment of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Yu-Qing ZhangDepartment of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Qian-Min GeDepartment of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Qiu-Yu LiDepartment of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Hui-Ye ShuDepartment of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Yi ShaoDepartment of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.ORCID 0000-0003-1571-2433
Nanchang University · CNXiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive ductal carcinoma (IDC) is a major type of breast cancer. Ocular metastasis (OM) in IDC is rarely seen, but patients with OM often have a poor prognosis. Furthermore, OM is difficult to detect in the early stages by common imaging examinations. In the present study, we tried to figure out the risk factors of OM in IDC and evaluate their diagnostic values for early detection. There were 1192 IDC patients who were divided into two groups according to ocular metastasis involved in this study. Clinical parameters of those patients were used to detect differences. The binary logistic regression test was then used to determine the risk factors of OM in IDC. Furthermore, ROC curves of both single and combined risk factors were established to examine their diagnostic values. The incidence of axillary lymph node metastases was significantly higher in the OM group (p = 0.002). Higher carbohydrate antigen 153 (CA153), lower apolipoprotein A1 (ApoA1), and hemoglobin (Hb) were risk factors for OM in IDC (p < 0.001, p < 0.001, p = 0.038, respectively). In the single risk factor ROC analysis, cutoff values of CA153, ApoA1, and Hb were 43.3 u/mL (CI: 0.966-0.984, p < 0.001), 1.11 g/L (CI: 0.923-0.951, p < 0.001), and 112 g/L (CI: 0.815-0.857, p < 0.001), respectively. Among the ROC curves of combined risk factors, CA153+ApoA1+Hb had the best accuracy, with the sensitivity and specificity of 89.47% and 99.32%, respectively (CI: 0.964-0.983, p < 0.001). CA153, ApoA1, and Hb are risk factors for OM in IDC. In clinical practice, the three parameters could be used as predictive factors for the early detection of OM.

Indexed as

AdultBiomarkers, TumorBreast NeoplasmsCarcinoma, Ductal, BreastCase-Control StudiesEye NeoplasmsFemaleFollow-Up StudiesHumansLymphatic MetastasisMiddle AgedPrognosisRetrospective StudiesRisk FactorsBiomarkers, Tumordiagnostic valueHIF-1invasive ductal cancerocular metastasisrisk factors

Identifiers

PMID33336932
PMCPMC7897965
OpenAlexW3112766716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.